Skip to content

Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women

Salt Lake Refugee Women's Health Project-Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02796586
Enrollment
17
Registered
2016-06-10
Start date
2015-07-31
Completion date
2017-05-31
Last updated
2017-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Refugee Health, Resettled Refugee, Family Planning, Contraception, Group Counseling, Group contraceptive counseling

Brief summary

To evaluate the feasibility and effectiveness of group contraceptive counseling on family planning knowledge acquisition, service satisfaction, method uptake and continuation among a group of resettled African refugee women.

Detailed description

Thousands of women refugees arrive in the United States each year, yet there is very little known about reproductive health and family planning needs of these women after resettlement. This randomized controlled pilot study, in a population of resettled African refugee women, will evaluate differences between group and individual contraceptive counseling on the decision to use contraception, satisfaction with counseling method, and modern family planning knowledge. Participants will arrive to clinic during an assigned intervention day. An intake and exit survey will be performed before and after their counseling session. Demographics, attitudes towards contraception, and knowledge regarding contraceptive methods will be assessed via questionnaire. Participants will be randomized to either group or individual contraceptive counseling. After each session, participants will have the option to privately choose a reversible method of contraception free of charge. Telephone survey follow-up with participants will occur every three months for one year. Follow-up surveys will include questions regarding method continuation, method satisfaction and and modern contraceptive knowledge.

Interventions

OTHERCounseling

Participants will be randomly assigned to group versus individual contraceptive counseling

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Resettled refugee * Ability to speak and comprehend conversational Swahili, French or Lingala * Interest in contraceptive counseling * Willing to adhere to study protocols including randomization and follow-up * Cellular phone access

Exclusion criteria

* Male

Design outcomes

Primary

MeasureTime frameDescription
Knowledge Acquisition assessed via number of correct questions on modified FogZone questionnaireDay of intervention (Study Day 1)Evaluate knowledge acquisition by comparing results on pre and post test of modern contraceptive knowledge. Contraceptive knowledge will be assessed using a modified version of the FogZone questionnaire
Contraceptive uptakeDay of intervention (Study day 1)Evaluate contraceptive uptake via query of method choice after counseling
Service Satisfaction via questionnaireDay of intervention (Study day 1)Evaluate satisfaction with service and type of counseling received using questionnaire
Service satisfaction via Likert ScaleDay of intervention (Study day 1)Evaluate satisfaction with service and type of counseling received using questionnaire

Secondary

MeasureTime frameDescription
Method Continuation3, 6, 9 and 12 months post-interventionEvaluate method continuation via telephone survey
Knowledge Retention assessed via modified FogZone questionnaire3, 6, 9 and 12 months post-interventionEvaluate knowledge retention by repeating knowledge questionnaire and comparing baseline and interval results.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026